MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


RNS News Service

I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.

Aon plc 8.3

RNS

RNS Number : 6541D
J.P. Morgan Securities LLC
29 October 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

AON plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.01 ordinary shares

Date of dealing

28 October 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 6,534,262  2.82

 2,636,467  1.15

(2) Derivatives (other than options)

 2,487,673  1.09

 77,085  0.03

(3)Optionsandagreementstopurchase/sell

 93,200  0.04

 

Total

 9,115,135  3.95

 2,713,552  1.18

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (USD)

 

  (Note 5)

Sale (Borrow Return)

 

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

21,700

 

3

1

44

18

28

2,200

365

7

639

1

5

205

4

35

10,340

21

2

1

2

1

3

44

100

202

102

1,136

 

100

200

1

300

200

400

100

2,200

200

1,005

97

87

2,416

639

368

35

15,726

3

232

100

202

1,136

NA

 

193.0333

193.3600

193.7500

193.8889

193.9532

193.9696

194.0996

194.1557

194.1976

194.2700

194.3460

194.3963

194.5050

194.6997

194.7000

195.0300

195.0650

195.1000

195.1800

195.3150

195.7500

196.0600

196.3200

196.3978

196.4696

199.4800

 

193.1300

193.3150

193.3600

193.5600

193.5900

193.6050

193.7400

193.9696

193.9750

194.0607

194.0700

194.1050

194.1223

194.1976

194.4227

194.6997

194.7000

195.0300

195.1445

195.5000

196.3978

199.4800

       

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD)

(Note 5)

Equity Swap

Long

 

 

 

Short

1,100

1,100

35

 

639

3

202

193.9523

193.9868

194.6997

 

194.1976

195.0300

196.3979

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price (USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any optionreferred to 

on   this   form   or   relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities 

to which any derivative referred to on this form is referenced. If none, this should be stated.

 

  None

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    Yes

 

Dateofdisclosure

29 October 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23

 

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Purchased

93,200

230.00 USD

American

15-Jan-21

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the   Rules. If in doubt, consult the Panel.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEPPGUAUUPUGPB